story of the week
Sustained Low Relapse Rate With Highly Variable B-Cell Repopulation Dynamics With Extended Rituximab Dosing Intervals in Patients With MS
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Neurology(R) Neuroimmunology & Neuroinflammation
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Sustained Low Relapse Rate With Highly Variable B-Cell Repopulation Dynamics With Extended Rituximab Dosing Intervals in Multiple Sclerosis
Neurol Neuroimmunol Neuroinflamm 2023 Jan 01;10(1)e200056, C Starvaggi Cucuzza, E Longinetti, N Ruffin, B Evertsson, I Kockum, M Jagodic, F Al Nimer, T Frisell, F PiehlFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.